The right time to apply to Y Combinator is when you have a founding team and an idea that excites that team.

There's a significant gap in funding for early-stage biotech discoveries, leading many companies to apply to Y Combinator when they have initial data suggesting a promising approach to curing diseases.

During the three-month Y Combinator program, biotech companies focus on refining their go-to-market strategy and understanding market requirements, which helps them secure necessary funding and capital.

Y Combinator is playing a significant role in funding young entrepreneurs in the biotech space, allowing them to advance their discoveries.

Y Combinator is an excellent platform for startups to gain focus and direction, especially during the critical incubation stage.

Joining Y Combinator turned out to be one of the best decisions I ever made, especially as we faced severe financial challenges before receiving their support. Starting and running a company as a founder can be a very lonely experience, where you often feel responsible for everyone's future and only you know the reality of the low times.

Biotech companies often use their time in Y Combinator to conduct critical path experiments and work with external companies for proof of concept studies, which can advance their regulatory filing status.

Applying to Y Combinator is a low time commitment with the potential for significant upside, making it a worthwhile opportunity for aspiring founders.

It's a misconception that being too far along in your startup's development disqualifies you from applying to Y Combinator; many successful applicants have raised significant funding before joining.